手术的作用in recurrent ependymomas and its contribution to the outcome are not well defined. While gross-total resection (GTR) has shown benefit in newly diagnosed patients with improvement in progression-free survival (PFS), its impact after recurrence is not known. Its role in distant relapses or multiple local recurrences is similarly less well understood. The objective of this study was to investigate whether GTR could prolong survival after recurrence.
In this paper, the authors identified patients with ependymomas who underwent surgery at Texas Children’s Hospital for recurrent ependymomas between December 2000 and December 2021. Surgical treatment was stratified as GTR, subtotal resection (STR), or a biopsy. Kaplan-Meier analysis was performed for PFS and overall survival (OS), and the log-rank test was used to assess statistical significance. The Cox regression model was used for multivariable analysis.
Forty children were identified with a first ependymoma recurrence and follow-up data were collected. The median age was 5.46 years (95% CI 4.52–6.39 years) with a mean follow-up of 3.92 years (95% CI 2.42–5.42 years). In 26 patients (65%), the original tumor was located in the infratentorial space. Twenty-nine patients (72.5%) presented with local recurrence. Within this group, the 5-year PFS rates for the GTR and STR groups were 40.1% and 26.8%, respectively. The 5- and 10-year OS rates were 58.3% and 50% in the GTR group and 51% and 16.7% in the STR group, respectively. Fifteen patients presented with a second recurrence. The 5-year PFS and OS rates in patients who had GTR after a second recurrence were 33% and 50%, respectively.
GTR of local recurrent ependymomas can result in long-term survival in first and second recurrences. Further and larger studies are necessary to elucidate the role of surgery in distal recurrences.
INCLUDE WHEN CITINGPublished online September 1, 2023; DOI: 10.3171/2023.7.PEDS2373.
DisclosuresThe authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
印第里凯托DJ,BradleyJA,RotondoRL,et al.Outcomes following proton therapy for pediatric ependymoma.Acta Oncol.2018;57(5):644–648.
印第里凯托DJ,Ioakeim-IoannidouM,BradleyJA,et al.Proton therapy for pediatric ependymoma: mature results from a bicentric study.Int J Radiat Oncol Biol Phys.2021;110(3):815–820.
荣格尔ST,AndreiuoloF,MynarekM,et al.Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.Childs Nerv Syst.2020;36(11):2693–2700.
LinFY,ChintagumpalaM.Advances in management of pediatric ependymomas.Curr Oncol Rep.2015;17(10):47.
RamaswamyV,HielscherT,MackSC,et al.Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis.J Clin Oncol.2016;34(21):2468–2477.
PattesonBE,BaligaS,BajajBVM,et al.Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy.Neuro Oncol.2021;23(1):156–166.
MerchantTE,BendelAE,SabinND,et al.Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma.J Clin Oncol.2019;37(12):974–983.
AntonyR,WongKE,PatelM,et al.A retrospective analysis of recurrent intracranial ependymoma.Pediatr Blood Cancer.2014;61(7):1195–1201.
ByerL,KlineCN,ColemanC,AllenIE,WhitakerE,MuellerS.A systematic review and meta-analysis of outcomes in pediatric, recurrent ependymoma.J Neurooncol.2019;144(3):445–452.
GuptaT,MaitreM,GuptaP,et al.re-excision程度,序列/抢救的时机re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.J Neurooncol.2020;147(2):405–415.
RitzmannTA,RogersHA,PaineSML,et al.A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.Pediatr Blood Cancer.2020;67(9):e28426.
TsangDS,BurghenE,KlimoPJr,BoopFA,EllisonDW,MerchantTE.Outcomes after reirradiation for recurrent pediatric intracranial ependymoma.Int J Radiat Oncol Biol Phys.2018;100(2):507–515.
ZapotockyM,BeeraK,AdamskiJ,et al.Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: cure at a cost.Cancer.2019;125(11):1867–1876.
MerchantTE,LiC,XiongX,KunLE,BoopFA,SanfordRA.Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study.Lancet Oncol.2009;10(3):258–266.
ElsamadicyAA,KooAB,DavidWB,et al.Comparison of epidemiology, treatments, and outcomes in pediatric versus adult ependymoma.Neurooncol Adv.2020;2(1):a019.
RuangkanchanasetrR,SwangsilpaT,PuataweepongP,et al.Outcome of postoperative radiation therapy for pediatric intracranial ependymoma: a single-institution review.Childs Nerv Syst.2019;35(8):1313–1321.
MontgomeryEY,ThirunavuV,PagadalaM,et al.Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.J Neurosurg Pediatr.2022;31(2):132–142.
MakDY,LaperriereN,RamaswamyV,et al.Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma—a multi-institutional study.Neurooncol Adv.2021;3(1):b158.
SaitoR,KumabeT,KanamoriM,SonodaY,TominagaT.Dissemination limits the survival of patients with anaplastic ependymoma after extensive surgical resection, meticulous follow up, and intensive treatment for recurrence.Neurosurg Rev.2010;33(2):185–192.
KanoH,YangHC,KondziolkaD,et al.Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas.J Neurosurg Pediatr.2010;6(5):417–423.
PaulinoAC.The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?Int J Radiat Oncol Biol Phys.2001;49(3):757–761.
ShahS,GatesK,MalloryC,et al.Effect of postoperative radiation therapy timing on survival in pediatric and young adult ependymoma.阿德Radiat杂志.2021;6(4):100691.
TsangDS,MurrayL,RamaswamyV,et al.Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.Neuro Oncol.2019;21(4):547–557.
WangE,GutkinPM,OhJ,et al.Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity.Neurosurg Focus.2022;53(5):E2.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 352 | 352 | 142 |
Full Text Views | 29 | 29 | 5 |
PDF Downloads | 37 | 37 | 6 |
EPUB Downloads | 0 | 0 | 0 |